Skip to main content
OpenTrials

Clinical trial condition

Adenoviridae Infections

Explore clinical trials studying Adenoviridae Infections. Study availability and eligibility vary by location and protocol.

92 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Adenoviridae Infections trial results

Completed

Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

NCT04693637

Conditions
Adenoviridae Infections, Adenovirus Infection, BK Virus Infection, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Francisco Medical Center San Francisco, California, United States
  • Childrens National Medical Center Northwest Rectangle, District of Columbia, United States
View all 16 locations
View Trial Details
Completed

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

NCT01431326

Conditions
Adenoviridae Infections, Adenovirus, Adrenal Gland Diseases, +162 more
Locations
  • Alaska Native Medical Center Anchorage, Alaska, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of California at San Diego Medical Center La Jolla, California, United States
  • Axis Clinical Trials Los Angeles, California, United States
View all 52 locations
View Trial Details
Completed

Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults

NCT00413725

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Soweto HVTN CRS Johannesburg, Gauteng, South Africa
  • MedCRU CRS Pretoria, Gauteng, South Africa
  • eThekwini CRS Durban, KwaZulu-Natal, South Africa
  • Emavundleni CRS Cape Town, Western Cape, South Africa
View Trial Details
Completed

Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults

NCT00486408

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States
  • Vanderbilt Vaccine (VV) CRS Nashville, Tennessee, United States
  • Seattle Vaccine and Prevention CRS Seattle, Washington, United States
View Trial Details
Completed

Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults

NCT00472719

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • Columbia P&S CRS New York, United States
  • New York Blood Center CRS New York, United States
View Trial Details

Related conditions